000 | 01020 a2200277 4500 | ||
---|---|---|---|
005 | 20250517173138.0 | ||
264 | 0 | _c20180613 | |
008 | 201806s 0 0 eng d | ||
022 | _a1479-6821 | ||
024 | 7 |
_a10.1530/ERC-17-0222 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCunha, Lucas Leite | |
245 | 0 | 0 |
_aImmunotherapy against endocrine malignancies: immune checkpoint inhibitors lead the way. _h[electronic resource] |
260 |
_bEndocrine-related cancer _c12 2017 |
||
300 |
_aT261-T281 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacology |
650 | 0 | 4 |
_aEndocrine Gland Neoplasms _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunotherapy _xmethods |
700 | 1 | _aMarcello, Marjory Alana | |
700 | 1 | _aRocha-Santos, Vinicius | |
700 | 1 | _aWard, Laura Sterian | |
773 | 0 |
_tEndocrine-related cancer _gvol. 24 _gno. 12 _gp. T261-T281 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1530/ERC-17-0222 _zAvailable from publisher's website |
999 |
_c27548893 _d27548893 |